The value of integrating national longitudinal shopping data into respiratory disease forecasting models.
Novo Nordisk’s weekly insulin rejected by FDA
The Food and Drug Administration rejected Novo Nordisk’s weekly insulin for the treatment of diabetes in a rare setback for the pharmaceutical giant. The agency
July 10, 2024